The Physician and sportsmedicine
However, different types of Semaglutide GLP-1 injections also exist
These are averagesindividual results vary
South Korea Semaglutide Market Size, Share, and COVID-19 Impact Analysis, By Product (Ozempic, Wegovy, and Rybelsus), By Application (Type 2 Diabetes Mellitus and Obesity), By Route of Administration (Parental and Oral), and South Korea Semaglutide Market Industry Trend, Forecasts to 2035 Industry: Healthcare South Korea Semaglutide Market Insights Forecasts to 2035 The South Korea Semaglutide Market Size Was Estimated at USD 195.34 Million in 2024 The Market Size is Expected to Grow at a CAGR of around 14.54% from 2025 to 2035 The South Korea Semaglutide Market Size is Expected to Reach USD 869.46 Million by 2035 Get more details on this report - Request Free Sample PDF According to a Research Report P ublished by Spherical Insights & Consulting, The South Korea Semaglutide Market Size is anticipated to Reach USD 869.46 Million by 2035, Growing at a CAGR of 14.54% from 2025 to 2035
7,8,17 Moreover, the dual GIP and GLP-1 receptor agonist tirzepatide has also recently been clinically approved for the same applications
